Byetta amylin Lilly

2007/03/22 16:57

Press Release from:

manu

Byetta, fondly referred to as “lizard spit”, seems to reverse all of these negative diabetes 2 processes and treatments quite handily. It is quite similar to GLP-1 having been altered slightly to be able to patent the molecule. There are other unique features that make it quite safe. It acts to,
• Increase first phase insulin response
• Increase late phase and total insulin production.
• It inhibits glucagon release
• It lowers its power as glucose goes to normal thus decreasing the chance of hypoglycemia.

Additionally it increases important

regulation of beta cell gene expression for the following.
• Glukinase – aids release of glycogen from liver
• Insulin production
• Glucose transporters – decreasing insulin resistance

Finally, Byetta will increase beta cell mass through replication of beta cell and decreased apoptosis.